SCHEMBL7512856

SCHEMBL7512856

CC=CCCCC=COC(=O)CC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 2/20 0.39
NR1I2 O75469 2/20 0.39
PTGS2 P35354 2/20 0.39
PGR P06401 1/20 0.39
PDE4D Q08499 1/20 0.39
ALDH1A1 P00352 8/20 0.37
CYP3A4 P08684 3/20 0.37
ALOX15 P16050 3/20 0.37
HSD17B10 Q99714 3/20 0.37
TDP1 Q9NUW8 3/20 0.37
TSHR P16473 1/20 0.37
PPARG P37231 5/20 0.35
PPARD Q03181 4/20 0.35
PPARA Q07869 4/20 0.35
F7 P08709 4/20 0.35
F3 P13726 4/20 0.35
CYP19A1 P11511 3/20 0.35
PTGS1 P23219 3/20 0.35
KMT2A Q03164 3/20 0.35
OXER1 Q8TDS5 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6936123 0.84 F7 (0.42) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL28588568 0.84 F7 (0.42) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL6936120 0.84 F7 (0.42) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL4962158 0.82 PPARG (0.47) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL30033951 0.82 MGLL (0.39) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL8379633 0.81 ALDH1A1 (0.49) ADORA3PGRALDH1A1CYP3A4ALOX15
SCHEMBL29519269 0.81 ALDH1A1 (0.49) ADORA3PGRALDH1A1CYP3A4ALOX15
SCHEMBL9941618 0.81 ALDH1A1 (0.49) ADORA3PGRALDH1A1CYP3A4ALOX15
SCHEMBL8018418 0.81 ALDH1A1 (0.49) ADORA3PGRALDH1A1CYP3A4ALOX15
SCHEMBL3194497 0.80 SOAT1 (0.34) ADORA3NR1I2PTGS2PGRPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10336966-B2 Fragrance compositions and uses thereof THE PROCTER & GAMBLE COMPANY (US) 2019-07-02 US claimed
EP-1165477-A1 METHOD FOR PRODUCING ALKAPOLYENYL COMPOUNDS USING CERTAIN COCATALYSTS BASF AKTIENGESELLSCHAFT (DE) 2002-01-02 EP disclosed
WO-2000059854-A1 METHOD FOR PRODUCING ALKAPOLYENYL COMPOUNDS USING CERTAIN COCATALYSTS BASF AKTIENGESELLSCHAFT (DE) 2000-10-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10336966-B2 Fragrance compositions and uses thereof CUTA, DPM1, PLIN5 ADORA3 4435/4885NR1I2 2241/4885PTGS2 2312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.